by According to Report, the Weight Loss Supplements Market is expected to grow at a CAGR of 17.6% during forecast period 2021 to 2030 and is projected to reach around US$ 120.6 billion by 2030.
Weight Loss Supplements Market (By Type: Liquid, Powder, Softgels, Pills; By Ingredient: Vitamins & Minerals, Amino Acids, Natural Extracts/ Botanicals; By End-user: Under 18 years, 18 to 40 years, 40 to 50 years, Above 50 years; By Distribution Channel: Offline Channel, Online Channel) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Get Free Sample Copy@ https://www.visionresearchreports.com/report/sample/38963
Report Coverage
| Report Scope | Details |
| Market Size | US$ 120.6 billion by 2030 |
| Growth Rate | CAGR of 17.6% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Type, Ingredients, End user, Distribution Channel |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Glanbia PLC; GlaxoSmithKline PLC; Herbalife Nutrition Ltd; Abbott; Kellogg Company; Kraft Heinz Company; Amway Corporation; Nestle; PepsiCo; Ajinomoto Co. Inc. |
Growth Factors
Rising cases of obesity across the globe coupled with increasing consumer awareness levels about following a healthier and fit lifestyle will drive the market. In addition, a rising number of fitness centers and gyms in several countries and increased awareness about the importance of weight loss supplements are projected to drive the market growth. Moreover, rising disposable income levels and improved accessibility & affordability of surgeries are propelling the market growth.
The rising cases of obesity and related health ailments, such as Cardiovascular Diseases (CVDs), diabetes, and hypertension, are expected to drive product demand.
By Type Analysis
The powders segment accounted for the highest revenue share of 33.7%. The powdered formulation makes provision of higher quantities of supplement and has a longer shelf life with the easily regulated dosages as per individual requirement, which is a driving factor for this segment.
The pills type segment is expected to record the fastest CAGR over the forecast years. Arise in preference for weight loss supplements in pills formulation due to the easy availability of the same in chewable tablets sustained-release pills, and sublingual pills is contributing to the segment growth.
Key Players
- Glanbia PLC
- GlaxoSmithKline PLC
- Herbalife Nutrition Ltd.
- Abbott
- Kellogg Company
- Nestle
- Kraft Heinz Company
- Amway Corp.
- PepsiCo
- Ajinomoto Co. Inc.
Market Segmentation
- By Type
- Liquid
- Powder
- Softgels
- Pills
- Others
- By Ingredient
- Vitamins & Minerals
- Amino Acids
- Natural Extracts/ Botanicals
- By End-user
- Under 18 years
- 18 to 40 years
- 40 to 50 years
- Above 50 years
- By Distribution Channel
- Offline Channel
- Online Channel
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Russia
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- UAE
- Saudi Arabia
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38963
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Weight Loss Supplements Market, By Type
7.1. Weight Loss Supplements Market, by Type, 2021-2030
7.1.1. Liquid
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Powder
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Softgels
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Pills
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Weight Loss Supplements Market, By Ingredient
8.1. Weight Loss Supplements Market, by Ingredient, 2021-2030
8.1.1. Vitamins & Minerals
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Amino Acids
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Natural Extracts/ Botanicals
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Weight Loss Supplements Market, By Distribution Channel
9.1. Weight Loss Supplements Market, by Distribution Channel, 2021-2030
9.1.1. Offline Channel
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Online Channel
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Weight Loss Supplements Market, By End user
10.1. Weight Loss Supplements Market, by End user, 2021-2030
10.1.1. Under 18 years
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. 18 to 40 years
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. 40 to 50 years
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Above 50 years
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Weight Loss Supplements Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.1.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.1.4. Market Revenue and Forecast, by End user (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.1.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.1.6.4. Market Revenue and Forecast, by End user (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.2.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.4. Market Revenue and Forecast, by End user (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.6.4. Market Revenue and Forecast, by End user (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.7.4. Market Revenue and Forecast, by End user (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Type (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.8.4. Market Revenue and Forecast, by End user (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.3.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.4. Market Revenue and Forecast, by End user (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.6.4. Market Revenue and Forecast, by End user (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.7.4. Market Revenue and Forecast, by End user (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.8.4. Market Revenue and Forecast, by End user (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.4. Market Revenue and Forecast, by End user (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.6.4. Market Revenue and Forecast, by End user (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.7.4. Market Revenue and Forecast, by End user (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.8.4. Market Revenue and Forecast, by End user (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.5.5.4. Market Revenue and Forecast, by End user (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Ingredient (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.5.6.4. Market Revenue and Forecast, by End user (2017-2030)
Chapter 12. Company Profiles
12.1. Glanbia PLC
12.1.1. Company Overview
12.1.2. Type Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GlaxoSmithKline PLC
12.2.1. Company Overview
12.2.2. Type Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Herbalife Nutrition Ltd.
12.3.1. Company Overview
12.3.2. Type Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Type Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kellogg Company
12.5.1. Company Overview
12.5.2. Type Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Nestle
12.6.1. Company Overview
12.6.2. Type Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Kraft Heinz Company
12.7.1. Company Overview
12.7.2. Type Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Amway Corp.
12.8.1. Company Overview
12.8.2. Type Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. PepsiCo
12.9.1. Company Overview
12.9.2. Type Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Ajinomoto Co. Inc.
12.10.1. Company Overview
12.10.2. Type Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38963
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
